PAINWeek 2025 is now accepting scientific poster abstract submissions. Showcase your groundbreaking research, gain global exposure, and connect with industry leaders. Don’t miss the chance to shape the future of pain management!
Abstracts may be:
Abstracts for posters that will report data need to include information on the methods and results sufficient for evaluation.
PAINWeek requires faculty and poster authors/presenters who have an interest in selling a technology, program, product, and/or service to healthcare professionals to disclose this information in order to be considered for and/or present at any PAINWeek educational session.
PAINWeek 2025 will feature live speaking opportunities for accepted abstracts. All speaking slots will be scheduled during exhibit hall breaks and receptions on the exhibit hall stage.
This 10-minute speaking opportunity will be available as a paid add-on for $7,500. Authors, presenters, or companies interested in this option to further highlight their accepted abstract can indicate their interest during the submission process.
This policy allows for the submission of late-breaking abstracts specifically for randomized Phase III trials under certain conditions.
During abstract submission, you must provide the date of the planned analysis. The final, updated late-breaking abstract deadline is July 9.
This policy is not intended for submitting updated data when preliminary results are already available by the regular abstract submission deadline.
This policy ensures that important, time-sensitive research can be included in the conference program while maintaining the integrity of the submission process.
CONTACT: Carli Rowe, Program Director
[email protected]
